Neudle.com: multiple sclerosis first attack

Differential
(Click to cross reference)

acute disseminated encephalomyelitis

adverse drug reaction

anti MAG antibodies

antibodies to myelin basic protein

antimyelin antibodies

Barkhof MR criteria for MS

cerebrospinal fluid, abnormal

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

controversies in neurology

conus medullaris, lesion of

cop 1

corproporphyrins

corpus callosum, lesion of

dementia

demyelinating disease

depression

diabetes insipidus

diagnostic criteria

differential diagnosis

disability rating scale, neurological

disability, neurological

efficacy

electroencephalogram

electroencephalogram, abnormalities of

epidemiology of neurology

Epstein-Barr virus

ethics in neurology

evoked potentials

extinction on double simultaneous stimulation

flu-like illness

fourth ventricle, shift of

gadolinium

gammaglobulin therapy, intravenous

hearing loss

hearing loss, sudden, unilateral

heralding manifestation

herpes virus

herpes virus infection

hydrocephalus

hydrocephalus, exvacuo

immunomodulation

immunosuppressive agents

infection

intellectual deficit

intellectual deterioration

leg weakness, unilateral

leukopenia

liver function enzymes

mania

manic-depressive

McDonald criteria for MS

memory, impairment of

MRI, contrast enhanced

MRI, demyelinating disease

MRI, false negative

MRI, field strength

MRI, field strength, high

MRI, incidental finding

multiple sclerosis, asymptomatic

multiple sclerosis, benign form of

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, cognitive presenttion

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, early onset

multiple sclerosis, etiology of

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, MRI conversion

multiple sclerosis, MRI criteria

multiple sclerosis, pathogenesis

multiple sclerosis, preclinical

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

N-acetyl-L-aspartic acid

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neuropathology

neuroprotective agents

neuropsychiatry

ocrelizumab

optic nerve, lesion of

optic neuritis

optic neuritis, bilateral

optic neuritis, children

optic neuritis, etiology of

optic neuritis, recurrent

optic neuritis, treatment of

optical coherence tomography

periventricular leukomalacia

placebo

posterior fossa

posterior fossa, lesion of

practice guidelines

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

protein 14-3-3, cerebrospinal fluid

psychiatric problems in neurologic disorders

seizure, non-treatment of

seizure, treatment of

seizure, treatment of, first

sensorineural hearing loss

serologic testing

spinal cord

spinal cord, cervical

spinal cord, lesion of

status epilepticus

steroid

steroid therapy, CNS treatment and complications with

symmetric brain lesions

symptomatic

tinnitus

treatment of neurologic disorder

ventricular enlargement

viral infection

viral infection, reactivation

visual evoked response

white matter disease

white matter disease, periventricular

workup

Showing articles 50 to 100 of 6244 << Previous Next >>

Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004

Acute Aphasia in Multiple Sclerosis, A Multicenter Study of 22 Patients
Neurol 62:974-977, Lacour,A.,et al, 2004

Role of Magnetic Resonance Imaging Within Diagnostic Criteria for Multiple Sclerosis
Ann Neurol 56:273-278, Miller,D.H.,et al, 2004

Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004

Long-Term Brain Magnetic Resonance Imaging Changes After Optic Neuritis in Patients Without Clinically Definite Multiple Sclerosis
Arch Neurol 61:1538-1541, Optic Neuritis Study Group, 2004

Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis
Archn Neurol 61:1515-1520, Achiron,A.,et al, 2004

Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes
Arch Neurol 61:222-224, Sastre-Garriga,J.,et al, 2004

The Utility of MRI in Suspected MS, Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 61:602-611,596, Frohman,E.M.,et al, 2003

Spinal Cord MRI in Clinically Isolated Optic Neuritis
JNNP 74:1577-1580, Dalton,C.M.,et al, 2003

New Diagnostic Criteria for Multiple Sclerosis
Neurol 60:27-30,6, Tintore,M.,et al, 2003

New T2 Lesions Enable an Earlier Diagnosis of Multiple Sclerosis in Clinically Isolated Syndromes
Ann Neurol 53:673-676, Dalton,C.M.,et al, 2003

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Validation of Diagnositc Magnetic Resonance Imaging Criteria for Multiple Sclerosis and Response to Interferon B1a
Ann Neurol 53:718-724, Barkhof,F.,et al, 2003

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003

Cognitive Presentation of Multiple Sclerosis: Evidence for a Cortical Variant
JNNP 74:872-877, Zarei,M.,et al, 2003

High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis
Arch Ophthalmol 121:944-949, Optic Neuritis Study Group, 2003

Course and Prognosis in Early-Onset MS
Neurol 59:1922-1928, Simone,I.L., etla, 2002

Management of Acute Optic Neuritis
Lancet 360:1953-1962, Hickman,S.J.,et al, 2002

A Longitudinal Study of Abnormalities on MRI and Disability From Multiple Sclerosis
NEJM 346:158-164,199, Brex,P.A.,et al, 2002

Interferon Beta-1a for Early Multiple Sclerosis: CHAMPS Trial Subgroup Analyses
Ann Neurol 51:481-490, Beck,R.W.,et al, 2002

Application of the New McDonald Criteria to Patients with Clinically Isolated Syndromes Suggestive of Mulitple Sclerosis
Ann Neurol 52:47-53, Dalton,C.M.,et al, 2002

Progressive Ventricular Enlargement in Patients with Clinically Isolated Syndromes is Associated with the Early Development of Multiple Sclerosis
JNNP 73:141-147, Dalton,C.M.,et al, 2002

MRI Predictors of Early Conversion to Clinically Definite MS in the CHAMPS Placebo Group
Neurol 59:998-1005, CHAMPS Study Group, 2002

Isolated Demyelinating Syndromes: Comparison of CSF Oligoclonal Bands and Different MR Imaging Criteria to Predict Conversion to CDMS
Mult Scler 7:359-363, Tintore,M.,et al, 2001

Assessing the Risk of Early Multiple Sclerosis in Patients with Clinically Isolated Syndromes: the Role of a Follow Up MRI
JNNP 70:390-393, Brex,P.A.,et al, 2001

Seizures in Multiple Sclerosis
Epilepsia 42:72-79, Sokic,D.V.,et al, 2001

Effect of Early Interferon Treatment on Conversion to Definite Multiple Sclerosis: A Randomised Study
Lancet 357:1576-1582,1547, Comi,G.,et al, 2001

Acute Motor Radiculopathy as a First Symptom of MS: Anatomic-radiologic Correlation
Neurol 56:1603-1604, Lavallee,P.,et al, 2001

Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
Ann Neurol 50:121-127, McDonald,W.I.,et al, 2001

14-3-3 Protein in the CSF as Prognostic Marker in Early Multiple Sclerosis
Neurol 57:722-724, Martinez-Yelamos,A.,et al, 2001

Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR 21:702-706, Tintore,M.,et al, 2000

Multiple Sclerosis--From Probable to Definite Diagnosis
Arch Neurol 57:974-979,930, Achiron,A. & Barak,Y., 2000

Intramuscular Interferon Beta-1a Therapy Initiated During a First Demyelinating Event in Multiple Sclerosis
NEJM 343:898-904, Jacobs,L.D. et al, 2000

Multiple Sclerosis in Children Under 6 Years of Age
Neurol 53:478-484, Ruggieri,M.,et al, 1999

Optic Neuritis as Onset Manifestations of Multiple Sclerosis
Neurol 53:473-478, Sorensen,T.L.,et al, 1999

Epilepsy in Patients with Multiple Sclerosis: Radiological-Clinical Correlations
Epilepsia 39:893-896, Moreau,Th.,et al, 1998

The 5-Year Risk of MS After Optic Neuritis
Experience of the Optic Neuritis Trtm Trial, Optic Neuritis Study Group, Neurol 49:1404-1413997., , 1997

Risk Factors for Developing Multiple Sclerosis after Childhood Optic Neuritis
Neurol 49:11413-1418, Lucchinetti,C.F.,et al, 1997

Patients with Multiple Sclerosis Presenting to Psychiatric Hospitals
J Clin Psychiatry 56:297-306, Pine,D.S.,et al, 1995

Epilepsy in Multiple Sclerosis
Eur Neurol 30:218-223, Ghezzi,A.,et al, 1990

Risk of Developing Multiple Sclerosis after Uncomplicated Optic Neuritis:A Long-Term Prospective Study
Neurol 38:185-190, Rizzo,J.F.&Lessell,S., 1988

The Early Risk of Multiple Sclerosis after Optic Neuritis
JNNP 51:1569-1571, Miller,D.H.,et al, 1988

Prevalence and Prognosis of Epilepsy in Patients with Multiple Sclerosis
Epilepsia 27:729-733, Kinnunen,E. &Wikstrom,J., 1986

Optic Neuritis & Multiple Sclerosis
Arch Neurol 42:702-704, Ebers,G.C., 1985

Optic Neuritis or Multiple Sclerosis
Arch Neurol 42:704-710, Kurtzke,J.F., 1985

Optic Neuritis & Multiple Sclerosis
NEJM 308:1294-1295, Link,H., 1983

A Prospective Study of the Risk of Developing Multiple Sclerosis in Uncomplicated Optic Neuritis
Neurol 29:208-213, Cohen,M.M.,et al, 1979

Optic Neuritis & Multiple Sclerosis
NEJM 280:1140, Arnason,B.G.W., 1973

Diabetes Insipidus As A First Manifestation In Multiple Sclerosis
, Thouvenot, E.,et al,

A 40-Year-Old Woman Presenting with Encepatholopathy and Paraparesis
Neurol 101:e94-e98, AlSabah,A.,et al, 2023

Showing articles 50 to 100 of 6244 << Previous Next >>